Literatura científica selecionada sobre o tema "BCL7"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "BCL7".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "BCL7"
Dietrich, Nicholas, Kevin Trotter, James M. Ward e Trevor K. Archer. "BRG1 HSA domain interactions with BCL7 proteins are critical for remodeling and gene expression". Life Science Alliance 6, n.º 5 (17 de fevereiro de 2023): e202201770. http://dx.doi.org/10.26508/lsa.202201770.
Texto completo da fonteJadayel, Dalal M., Lucy R. Osborne, Lionel J. A. Coignet, Valter J. Zani, Lap-Chee Tsui, Stephen W. Scherer e Martin J. S. Dyer. "The BCL7 gene family: deletion of BCL7B in Williams syndrome". Gene 224, n.º 1-2 (dezembro de 1998): 35–44. http://dx.doi.org/10.1016/s0378-1119(98)00514-9.
Texto completo da fonteMcBride, Amanda, Clare M. Adams, Ramkrishna Mitra e Christine M. Eischen. "Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas". Blood 136, Supplement 1 (5 de novembro de 2020): 29. http://dx.doi.org/10.1182/blood-2020-142545.
Texto completo da fonteKahraman, Dudu Solakoglu, Gulden Diniz, Cengiz Ceylan, Faruk Recep Ozalp, Yetkin Koca, Sumeyye Ekmekci, Duygu Ayaz e Sevil Sayhan. "Prognostic impact of BCL2, BCL6 and MYC status in de novo diffuse large B-cell lymphoma: a regional study of 43 patients". International Journal of Research in Medical Sciences 7, n.º 5 (26 de abril de 2019): 1720. http://dx.doi.org/10.18203/2320-6012.ijrms20191665.
Texto completo da fonteSun, Guoxian, e Lya Montella. "Oncogene Amplification as an Incidental Finding in FISH Testing for Gene Rearrangements in Lymphoid Hematopoietic Neoplasms". Blood 118, n.º 21 (18 de novembro de 2011): 2505. http://dx.doi.org/10.1182/blood.v118.21.2505.2505.
Texto completo da fonteGonzález de Villambrosia, Sonia, Mercedes Colorado, Andres Insunza, Ana Batlle, Brenda López-Pereira, Guillermo Martin, Paloma Ibarrondo, Santiago Montes-Moreno e Eulogio Conde. "B Cell Lymphoma Unclassifiable, with Features Intermediate Between Diffuse Large B Cell Lymphoma and Burkitt Lymphoma and Diffuse Large B Cell Lymphoma NOS with Doble/Triple Translocations: Immunophenotypic Analysis". Blood 126, n.º 23 (3 de dezembro de 2015): 5037. http://dx.doi.org/10.1182/blood.v126.23.5037.5037.
Texto completo da fonteLeski, Tomasz A., Clayton C. Caswell, Marcin Pawlowski, David J. Klinke, Janusz M. Bujnicki, Sean J. Hart e Slawomir Lukomski. "Identification and Classification of bcl Genes and Proteins of Bacillus cereus Group Organisms and Their Application in Bacillus anthracis Detection and Fingerprinting". Applied and Environmental Microbiology 75, n.º 22 (18 de setembro de 2009): 7163–72. http://dx.doi.org/10.1128/aem.01069-09.
Texto completo da fonteDupont, Thibault, Zhenghong Dong, ShaoNing Yang, Ari Melnick e Leandro Cerchietti. "Combinatorial Targeting of BCL6 and Anti-Apoptotic Proteins in Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)". Blood 120, n.º 21 (16 de novembro de 2012): 64. http://dx.doi.org/10.1182/blood.v120.21.64.64.
Texto completo da fontePophali, Priyanka, Lisa M. Marinelli, Rhett P. Ketterling, Reid Gregory Meyer, Ellen D. McPhail, Paul J. Kurtin, Thomas M. Habermann e Rebecca L. King. "High Level MYC Amplification in Aggressive B-Cell Lymphomas: Is It a Marker of Aggressive Disease?" Blood 132, Supplement 1 (29 de novembro de 2018): 1693. http://dx.doi.org/10.1182/blood-2018-99-115484.
Texto completo da fontePedersen, Mette Ølgod, Anne Ortved Gang, Tim Svenstrup Poulsen, Helle Knudsen, Anne F. Lauritzen, MajLis M. Talman, Signe Ledou Nielsen e Peter H. Norgaard. "Concurrent BCL2 and MYC Translocations In a Prospective Cohort of Diffuse Large B-Cell Lymphomas". Blood 116, n.º 21 (19 de novembro de 2010): 319. http://dx.doi.org/10.1182/blood.v116.21.319.319.
Texto completo da fonteTeses / dissertações sobre o assunto "BCL7"
Martin, Franck. "Structural and functional studies of chromatin remodeling complex mamalian SWI / SNF". Electronic Thesis or Diss., Strasbourg, 2024. http://www.theses.fr/2024STRAJ044.
Texto completo da fonteChromatin is a dynamic structure regulated by various epigenetic mechanisms, including ATP-dependent chromatin remodeling such as SWI/SNF. Their importance is such that mutations in chromatin remodeling proteins are strongly associated with several diseases, including cancer. For example, BCL7 proteins, which are newly identified core subunits of the mammalian SWI/SNF complex, are associated with different types of cancer, such as Diffuse Large B-cell Lymphoma (DLBCL). To date, information on BCL7 proteins is very limited. Using biochemical and structural approaches, this project aims to better understand the structure and function of these auxiliary subunits. We report here that the proteins bind to the nucleosome with its N-terminal regions, which include an arginine anchoring motif, and that mutation of one of these arginines directly impacts binding to the nucleosome. We also hypothesize that the position within the SWI/SNF complex of BCL7, which interacts with the ARP module and more specifically with ACTB via a 2W motif, is directly linked to BAF47. We were also able to identify that once on the nucleosomes, BAF47 takes its place on the acidic patch and the BCL7A helix is displaced
Barrans, Sharon Louise. "Immunophenotypic and molecular approaches to the classification of diffuse large B cell lymphoma". Thesis, Manchester Metropolitan University, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.366169.
Texto completo da fonteLi, Yue. "Investigating Selected Mechanisms of Modulation of BECN1-mediated Autophagy". Diss., North Dakota State University, 2019. https://hdl.handle.net/10365/29775.
Texto completo da fonteNIH: RO3 NS090939, R15 GM122035, P20 RR015566, and R21 AI078198 (S.S). R15 GM113227, P30 GM103332-01, P41 GM103622, and P41 GM103403.; NSF: MCB-1413525 (S.S.); ND Dept. of Commerce: Award #14-11-J1-73 (S.S.)
Thompson, Brian M. "Amino-terminal sequences of the bacillus anthracis exosporium proteins BCLA and BCLB important for localization and attachment to the spore surface". Diss., Columbia, Mo. : University of Missouri-Columbia, 2008. http://hdl.handle.net/10355/5700.
Texto completo da fonteThe entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. "August 2008" Includes bibliographical references.
Kunze, Doreen. "Small interfering RNA-vermittelte Hemmung der Apoptoseinhibitoren BCL2, BCL-XL, XIAP und Survivin in Zellkultur- und Mausmodellen des humanen Harnblasenkarzinoms". Doctoral thesis, Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2012. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-81888.
Texto completo da fonteMahn, Friederike Marie [Verfasser]. "Bruchereignisse in den Onkogenorten BCL2, BCL6 und MYC bei aggressiven B-Zell-Lymphomen im Kindesalter : molekularzytogenetische Analysen im Rahmen der NHL-BFM-Studie / Friederike Maria Mahn". Kiel : Universitätsbibliothek Kiel, 2010. http://d-nb.info/101998337X/34.
Texto completo da fonteViant, Charlotte. "Régulation du développement et de la fonction des cellules innées lymphoïdes NKp46+". Thesis, Aix-Marseille, 2016. http://www.theses.fr/2016AIXM4018/document.
Texto completo da fonteThere are three groups of innate lymphoid cells (ILC), defined notably by the transcriptions factors essential to their differentiation and their cytokines secretion. ILC1, including natural killer (NK) cells, express T-bet and secrete IFN-γ. ILC2 are characterized by GATA3 expression and the production of IL-5 and IL-13. ILC3 secrete IL-17 and IL-22 and express RORγt.My PhD work dealt with different aspects of NK cells and ILC3: their tolerance, homeostasis and plasticity.NK cell are involved in killing tumor cells and bacteria- or virus-infected cells. I found that the phosphatase SHP-1 (Src homology region 2 domain-containing phosphatase-1) has a role in NK cell tolerance and activation.I also showed that the anti-apoptotic Bcl2 protein (B-cell lymphoma 2) is important for NK cell homeostasis. Only cycling NK cells could compensate the Bcl2 deficiency, due to the increase expression of another anti-apoptotic protein, Mcl1 (Myeloid Cell Leukemia 1).ILC3 are mainly located in the gut and are classified in different groups, depending on the markers that they expressed. I showed that there is plasticity between ILC3 populations and that this plasticity is regulated by environmental factors, including TGF-β and the Notch ligand, DL1
Hakert, James Damian. "The crosstalk between notch1 and BCL6". Tallahassee, Fla. : Florida State University, 2010. http://purl.fcla.edu/fsu/lib/digcoll/undergraduate/honors-theses/2181936.
Texto completo da fonteAdvisor: Dr. Yoichi Kato, Florida State University, College of Arts and Sciences, Dept. of Chemistry and Biochemistry. Includes bibliographical references.
Warner, Andrew. "Borylative cyclisation of alkynes using BCl3". Thesis, University of Manchester, 2017. https://www.research.manchester.ac.uk/portal/en/theses/borylative-cyclisation-of-alkynes-using-bcl3(7a4e56f3-e8c6-4c68-97ec-4596ef5e0ce2).html.
Texto completo da fonteLeal, Cristina Tavares. "Identificação da família BCL2 como alvo terapêutico no tratamento das neoplasias mieloproliferativas associadas à mutação da JAK2V617F". Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/17/17154/tde-06042018-114114/.
Texto completo da fonteMyeloproliferative Neoplasms (MPNs) negative for t(9;22)/BCR-ABL1 rearrangement, including Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF), are clonal hematopoietic diseases and are often associated with the JAK2V617F mutation. Despite advances in the pathophysiology knowledge after the discovery of the JAK2V617F mutation and the development of JAK2 inhibitors, treatment remains non-curative. It is known that MPN primitive stem cells are essential for the initiation of the disease and that the expansion of the myeloeritroid precursors contributes to the clinical phenotype. Recent data, obtained with in vitro assays, showed that BCL2 family proteins, regulators of mitochondrial apoptosis, play a relevant role in the pathogenesis of MPNs. We believe that the anomalous expression of BCL2 in hematopoietic progenitor cells (HPCs) of MPNs may contribute to their pathogenesis. We evaluated BCL2 family (antiapoptotic genes BCL-xL and BCL2 and the pro-apoptotic BIM) gene expression by real-time PCR in different subpopulations of hematopoietic progenitors from a conditional Jak2V617F knockin murine model and from patients with MPNs as well as their contribution to the disease phenotype and response to JAK2 inhibitors (with ruxolitinib) and/or to the inhibition of the BCL2 family (with the BH3-mimetic obatoclax). We found no difference in the basal expression of the BCL2, BCL-xL and BIM in CD34+ cells as well as in subpopulations of CD34+ 38-/+ cells from patients with MPNs, regardless of the presence of the JAK2V617F mutation. In CD34+ cells obtained from patients with ET, we found an increase of BCL2 expression when compared to CD34+ cells with PMF (p=0.03). In the Jak2 wt/VF transgenic mice (that develop a MPN similar to PV) and Jak2 wt/wt controls, we compared the differential expression of Bcl2 family genes in immature hematopoietic precursors (LSKs) and more mature myeloid progenitors (MPs). Expression of Bcl-xL in MPs of wt/VF mice was greater when compared to LSKs and to the two progenitor subpopulations of control cells (p=0.0011). There was no significant difference in Bcl2 expression between the subpopulations of LSKs and MPs from wt/VF and wt/wt animals (p=0.12). Lower Bim expression in LSKs than in MPs was observed in samples from JAK2-mutated animals (p=0.026). Such difference was not observed between the Jak2 wt/wt subpopulations. Treatment with JAK2 or BCL2 inhibitors alone resulted in increased Bim expression in LSKs and MPs of the Jak2 wt/VF mice when compared to Jak2 wt/wt animals. This increase in Bim expression was even more evident when these cells were treated with the combination of the two drugs as compared to single treatment with one of the two inhibitors, being higher in mutaded than control animals (p<0.0001). The analysis of apoptosis by flow cytometry (annexin / 7-AAD labeling) revealed that LSK cells were more resistant to late apoptosis than MP cells regardless of the JAK2 mutation (p<0.05). Treatment with obatoclax resulted in greater apoptosis induction than it was observed with ruxolitinib treatment (p=0.594) on MP cells of Jak2 wt/VF animals. In addition, the combined treatment with ruxolitinib and obatoclax resulted in increased apoptosis in MP cells of animals with the PV phenotype (Jak2 wt/VF) as compared to the Jak2 wt/wt animals (p=0.05). In conclusion, we demonstrated that resistance to apoptosis in MPNs occurs at the level of the hematopoietic progenitors that initiate the disease. Our results suggest that modulation of mitochondrial apoptosis may be a new therapeutic strategy for MPN patients in combination with JAK2 inhibitors, as it acts on both the disease initiating and more mature progenitors, responsible for the clinical findings of myeloproliferation.
Livros sobre o assunto "BCL7"
Gavathiotis, Evripidis, ed. BCL-2 Family Proteins. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-8861-7.
Texto completo da fonteHetz, Claudio, ed. BCL-2 Protein Family. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-6706-0.
Texto completo da fonteGuelachvili, G., ed. Linear Triatomic Molecules - BClH+ (HBCl+) - COSe (OCSe). Berlin/Heidelberg: Springer-Verlag, 1995. http://dx.doi.org/10.1007/b46104.
Texto completo da fonteWeil, Harry H. Structuring the smaller corporation under the BCL. [Harrisburg, Pa.] (P.O. Box 1027, Harrisburg 17108-1027): Pennsylvania Bar Institute, 1989.
Encontre o texto completo da fonteCatholic Church. National Conference of Catholic Bishops. Committee on the Liturgy. Thirty-five years of the BCL newsletter. Washington, D.C: United States Conference of Catholic Bishops, 2004.
Encontre o texto completo da fonteBeaton, Jennifer. Amplification and cloning of Bcl-xL and Bcl-xS to obtain in-vitro production of protein products. Sudbury, Ont: Laurentian University, 1995.
Encontre o texto completo da fonteUnited States. National Aeronautics and Space Administration., ed. The apparent strain stability and repeatability of a BCL3 resistance strain gage. [Washington, DC]: National Aeronautics and Space Administration, 1991.
Encontre o texto completo da fonteTomlin, Jennifer Leigh. Novel biological approaches for detecting oncogenic cooperation with Bcl-2. Ottawa: National Library of Canada, 1999.
Encontre o texto completo da fonteConference, British Comparative Literature Association. Literary representations of the self: Papers from the fifth triennial BCLA conference 1989. Oxford: Oxford University Press for the University of St Andrews, 1990.
Encontre o texto completo da fonteWachek, Volker. Einfluss der BCL-2 Expression auf die Chemoresistenz des malignen Melanoms. [s.l.]: [s.n.], 1997.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "BCL7"
Posypaiko, V. I., e E. A. Alekseeva. "BCl3". In Phase Equilibria in Binary Halides, 26. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-9024-4_10.
Texto completo da fonteRuggiero, Marco, e John W. Anderson. "Bcl2". In Encyclopedia of Cancer, 1–7. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_562-4.
Texto completo da fonteRuggiero, Marco, e John W. Anderson. "Bcl2". In Encyclopedia of Cancer, 1–6. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-642-27841-9_562-5.
Texto completo da fonteBrocke-Heidrich, Katja. "BCL3". In Encyclopedia of Cancer, 1–4. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_565-2.
Texto completo da fonteRuggiero, Marco, e John W. Anderson. "Bcl2". In Encyclopedia of Cancer, 447–52. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_562.
Texto completo da fonteBrocke-Heidrich, Katja. "BCL3". In Encyclopedia of Cancer, 452–55. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_565.
Texto completo da fonteRuggiero, Marco. "Bcl2". In Encyclopedia of Cancer, 356–60. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_562.
Texto completo da fonteBrocke-Heidrich, Katja. "BCL3". In Encyclopedia of Cancer, 361–63. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_565.
Texto completo da fonteSaidak, Zuzana, Zakaria Ezzoukhry, Jean-Claude Maziere, Antoine Galmiche, Ken-Ichi Takemaru, Xingwang Chen, Feng-Qian Li et al. "BAX (BCl2-Associated X Protein), BCL2L4 (BCL-2 Like 4)". In Encyclopedia of Signaling Molecules, 186. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_100109.
Texto completo da fonteVini, Ravindran, Sreeja Sreekumar, Juberiya M. Azeez e Sreeja Sreeharshan. "Pomegranate Extract Protects Endothelial Cells from TNF-α Associated Damage". In Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022), 276–89. Dordrecht: Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-020-6_27.
Texto completo da fonteTrabalhos de conferências sobre o assunto "BCL7"
Salame, Jéssica Paola, Lucas Loss Cantele, Gabriela Gavasso, Beliza Loss e Karla Patricia Casemiro. "LINFOMA DIFUSO DE GRANDES CÉLULAS B CUTÂNEO SECUNDÁRIO À DOENÇA TESTICULAR PRÉVIA, COM 4 ANOS DE INTERVALO - RELATO DE CASO". In I Congresso Brasileiro de Estudos Patológicos On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/conbesp/18.
Texto completo da fonteHoppe, Michal, Shuangyi Fan, Patrick Jaynes, Phuong Mai Hoang, Liu Xin, Sanjay De Mel, Li Mei Poon et al. "Abstract PO-35: Prognostic significance of MYC, BCL2, and BCL6 colocalization at single-cell resolution in DLBCL". In Abstracts: AACR Virtual Meeting: Advances in Malignant Lymphoma; August 17-19, 2020. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2643-3249.lymphoma20-po-35.
Texto completo da fonteZoeller, JJ, RT Bronson, D. Sampath, J. Leverson e JS Brugge. "Abstract P4-14-02: Neutralization of BCL2/BCL-XL enhances the cytotoxicity of T-DM1 in vivo". In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p4-14-02.
Texto completo da fonteOnen, Onursal, Alper Sisman, Patricia Kruk e Rasim O. Guldiken. "An Urinary Biosensor for Early Stage Ovarian Cancer Detection: Experimental Characterization". In ASME 2012 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/imece2012-87850.
Texto completo da fonteBrock, Benjamin, Aydın Buluç e Katherine Yelick. "BCL". In ICPP 2019: 48th International Conference on Parallel Processing. New York, NY, USA: ACM, 2019. http://dx.doi.org/10.1145/3337821.3337912.
Texto completo da fonteWalters, Madeline A., Zhaoyan Fan e Burak Sencer. "Data-Based Modeling for Reactive Ion Etching: Effectiveness of an Artificial Neural Network Model for Estimating Tungsten Silicon Nitride Etch Rate". In ASME 2020 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2020. http://dx.doi.org/10.1115/imece2020-23992.
Texto completo da fonteOnen, Onursal, Patricia Kruk e Rasim Guldiken. "Design of Urinary Biomarker Sensor for Early Ovarian Cancer Detection". In ASME 2011 International Mechanical Engineering Congress and Exposition. ASMEDC, 2011. http://dx.doi.org/10.1115/imece2011-62818.
Texto completo da fonteHuang, Zi-Xian, e Chuan-Xian Ren. "Rethinking Correlation Learning via Label Prior for Open Set Domain Adaptation". In Thirty-Third International Joint Conference on Artificial Intelligence {IJCAI-24}. California: International Joint Conferences on Artificial Intelligence Organization, 2024. http://dx.doi.org/10.24963/ijcai.2024/98.
Texto completo da fonteMartinez Torre, S., C. Carreño, L. Sordo, AE Llosa, J. Ousley, A. Waziri, R. Mathela, RD Umar, J. Usman e MJ Sagrado. "Severity, symptomatology, and treatment duration for paediatric mental health disorders: A retrospective analysis from a conflict affected region of northern Nigeria". In MSF Paediatric Days 2022. NYC: MSF-USA, 2022. http://dx.doi.org/10.57740/88gr-bc57.
Texto completo da fonteYue, Lok Man, David Hau Wing Chau, Wenying Piao, (Eric) Wai Choi Tse e Yok Lam Kwong. "Abstract 2166: Arsenic trioxide targets BCL6 oncoprotein for degradation in BCL6-dependent diffuse large B-cell lymphoma". In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-2166.
Texto completo da fonteRelatórios de organizações sobre o assunto "BCL7"
Machen, Terry. BCL-2, Ca, and Apoptosis in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2000. http://dx.doi.org/10.21236/ada394121.
Texto completo da fonteKim, Hyeong-Reh. Role of Bcl-2 in Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, agosto de 1999. http://dx.doi.org/10.21236/ada383052.
Texto completo da fonteXu, Liang. Tumor-Targeted Silencing of Bcl-2/Bcl-xl by Self-Assembled Sirna-Nanovectors as a Novel Molecular Therapy for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2007. http://dx.doi.org/10.21236/ada475350.
Texto completo da fonteMarassi, Francesca M. Structural Basis for Bcl-2-Regulated Mitochondrion-Dependent Apoptosis. Fort Belvoir, VA: Defense Technical Information Center, abril de 2004. http://dx.doi.org/10.21236/ada429719.
Texto completo da fonteJamerson, Matthew. Cooperation of Bcl-XL and c-Myc in Mammary Tumorigenesis. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2000. http://dx.doi.org/10.21236/ada396438.
Texto completo da fonteShul, R. J., C. I. H. Ashby, C. G. Willison, L. Zhang, J. Han, M. M. Bridges, S. J. Pearton, J. W. Lee e L. F. Lester. GaN etching in BCl{sub 3}Cl{sub 2} plasmas. Office of Scientific and Technical Information (OSTI), abril de 1998. http://dx.doi.org/10.2172/658195.
Texto completo da fonteSchor, Nina F. Exploiting BCL-2 Overexpression in the Chemotherapy of Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, junho de 1998. http://dx.doi.org/10.21236/ada350950.
Texto completo da fonteJamerson, Matthew H. Cooperation of Bcl-xL and c-Myc in Mammary Tumorigenesis. Fort Belvoir, VA: Defense Technical Information Center, agosto de 1999. http://dx.doi.org/10.21236/ada391341.
Texto completo da fonteNunez, Gabriel. Molecular Analysis of Bcl-xs-Induced Apoptosis in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, julho de 2000. http://dx.doi.org/10.21236/ada384375.
Texto completo da fonteKennedy, C. H., K. D. Kenyon e J. Tesfaigzi. Transfection of normal human bronchial epithelial cells with the bcl-2 oncogene. Office of Scientific and Technical Information (OSTI), dezembro de 1995. http://dx.doi.org/10.2172/381812.
Texto completo da fonte